A publicly traded global pharmaceutical company and several former executives settled SEC charges for making misleading disclosures to investors in financial reports and earning presentations.

A broker-dealer settled FINRA charges for failing to establish and maintain adequate supervisory systems on private placements for contingency offerings.

OFAC designated a Chinese company and two individuals to the Specially Designated Nationals and Blocked Persons List. The designations were linked to human rights abuse in the Xinjiang Uyghur Autonomous Region.

The U.S. House Committee on Financial Services considered testimony from CFPB Director Kathleen L. Kraninger on the Bureau's Spring 2020 Semi-Annual Report.

An SEC-proposed rule amending Form 13F to (i) modernize its data reporting framework, (ii) update the instructions for confidential treatment requests and (iii) raise the reporting threshold for institutional investment managers from $100 million to $3.5 billion was published in the Federal Register.